Delivery Order FA486122D0002-FA486125F0011
Award Date
11/7/24
Potential Completion Date
9/30/25
Potential Value
$17K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Air Combat Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Nellis AFB, NV, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
Immucor Inc. has been awarded a $59,188.35 delivery order against its Federal Supply Schedule contract for blood bank reagents. The contract calls for Immucor to provide blood typing, compatibility testing, antibody screening, and other critical reagents to support the blood banking operations of the Defense Health Agency. Performance will take place in Norcross, Georgia through September 30, 2023. As the prime contractor for this delivery order, Immucor will leverage its expertise in...
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a leading provider of automated in vitro diagnostic solutions for blood banking and transplantation. The contract, valued at $114,014.55, is for the delivery of Immucor's specialized reagents to support blood typing, compatibility testing, and other critical blood banking operations within military treatment facilities and federal healthcare networks. The contract is a firm fixed-price...
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
This is a delivery order contract awarded to Immucor Inc. by the Department of the Army Medical Command for the provision of blood typing reagents. The contract has a potential value of $120,612.04 and a completion date of September 30, 2019. Immucor Inc. is a manufacturer of in vitro diagnostic products, reagents, and test kits for blood transfusion and transplantation compatibility testing. The contract was not set aside for any specific business category. Immucor has held previous federal...
This contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, is for the delivery of blood reagents, test kits, and diagnostic products to support the testing programs and healthcare services of the Defense Health Agency (DHA). The $260,536.03 firm fixed-price delivery order was issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. The award does not have a...
This is a delivery order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Immucor Inc. for the annual supply of blood testing reagents. The award, which has a ceiling value of $130,059.42, is made under Immucor's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. As a firm fixed-price contract, this delivery order does not utilize any set-aside designations. Immucor is a leading provider of automated...
This is a federal delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The $101,999.52 firm-fixed-price contract is for the provision of blood bank reagents to support blood transfusion and compatibility testing programs. It was awarded under Immucor's General Services Administration (GSA) Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle for in vitro diagnostics, reagents, and test kits. The...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...